Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 01, 2026
Accenture (ACN) Stock Declines -36.7% Over 30 Days Following Earnings Miss and Guidance Cut

Accenture (ACN) Stock Declines -36.7% Over 30 Days Following Earnings Miss and Guidance Cut

Key Takeaways

  • Accenture shares tumbled approximately 36.7% over the last 30 days, driven primarily by a disappointing fiscal third-quarter earnings report and reduced full-year revenue guidance.
  • The stock suffered its worst single-day decline on record on June 18, 2026, plunging roughly 18-20% after the company trimmed its FY2026 growth outlook.
  • Management lowered full-year local-currency revenue growth guidance to 3-4% from the prior 3-5% range, citing U.S. federal spending cuts and Middle East conflict disruptions.
  • A simultaneous $4.18 billion cybersecurity acquisition announcement raised investor concerns about capital allocation priorities amid slowing organic growth.
  • Multiple Wall Street analysts downgraded the stock or slashed price targets, with the stock now down more than 50% year-to-date.

Accenture’s Business and Market Position

Accenture is a global professional services leader, helping the world’s largest enterprises reinvent their businesses through strategy, consulting, digital transformation, technology, and operations services. With a workforce of approximately 799,000 people serving roughly 9,000 clients across more than 120 countries, the company generated approximately $70 billion in revenue in fiscal 2025. Accenture’s business is divided between consulting services and managed services, with deep expertise spanning cybersecurity, AI and data, cloud migration, supply chain, and industry-specific solutions. The company is widely viewed as a bellwether for enterprise IT spending and has positioned itself as a primary partner for organizations navigating large-scale AI adoption.

Stock Price Performance Over the Last 30 Days and Quarter

Over the last 30 days, ACN stock has experienced a dramatic decline of approximately 36.7%, falling from a closing price of $196.59 on June 1, 2026, to $124.44 as of June 30, 2026. The most severe single-day move occurred on June 18, when shares cratered roughly 18-20% following the company’s fiscal Q3 earnings release and guidance cut. The stock continued to face selling pressure in subsequent sessions, touching a 52-week low of $118.15 on June 22 before stabilizing in the $124-$129 range. Over the broader quarter, the decline has been even more pronounced, with shares down more than 50% year-to-date, reflecting a sustained repricing as investors grapple with slowing growth, AI disruption fears, and macroeconomic headwinds.

What Drove the Recent Sell-Off

The primary catalyst for the sharp sell-off was Accenture’s fiscal third-quarter 2026 earnings report released on June 18. While the company beat earnings-per-share estimates with $3.80 versus the $3.71 consensus, revenue of $18.72 billion narrowly missed expectations of $18.78 billion. More critically, management lowered the top end of its full-year revenue growth guidance from 3-5% to 3-4% in local currency and issued Q4 revenue guidance of $17.75 billion to $18.40 billion, well below the $18.47 billion analyst consensus. New bookings fell 2% year-over-year to $19.3 billion, signaling softening demand. Compounding the negative sentiment, Accenture simultaneously announced $4.18 billion in cybersecurity acquisitions — a majority stake in Dragos and full purchases of runZero and NetRise — which investors viewed as a costly capital allocation decision during a period of decelerating organic growth. CEO Julie Sweet disclosed that the Middle East conflict reduced revenue by $100 million in the quarter and impacted sales by roughly $400 million, while U.S. federal government cost-cutting continued to weigh on the company’s public-sector business. Several analysts, including William Blair’s Maggie Nolan and Morgan Stanley’s James Faucette, downgraded the stock or cut price targets sharply, with Citi lowering its target from $195 to $135. I also checked the relative performance using Tickeron’s AI Screener to see how ACN compares to peers.

Broader Pressures Over the Quarter

Accenture’s quarterly decline reflects a convergence of structural and cyclical pressures that have intensified throughout 2026. The stock entered the year near $259 and has since lost more than half its value. A major overhang has been the impact of federal government cost-cutting initiatives, which management quantified as a roughly 1% drag on full-year revenue growth. Beyond government exposure, a deeper investor concern has taken hold: the fear that agentic AI tools could fundamentally disrupt the consulting business model by automating tasks that previously required billable hours. Consulting revenue grew only 1% in local currency during Q3, lending weight to the bear case. Broader IT services peers such as IBM and Capgemini also sold off in sympathy, suggesting industry-wide demand concerns rather than company-specific issues. Despite posting record bookings of $22.1 billion in the prior quarter and generating $3.6 billion in free cash flow in Q3, the market has focused squarely on the decelerating growth trajectory and the uncertain timeline for AI-related consulting revenue to materialize at scale.

Using Data-Driven Tools in Volatile Markets

In volatile market environments like the one currently affecting ACN, I often turn to data-driven tools to help navigate uncertainty. Tickeron’s Trending AI Robots page offers a curated selection of AI-powered trading bots designed to identify opportunities across thousands of tickers. These bots employ diverse strategies, timeframes, and performance metrics, with only the top-performing and most relevant models featured. Whether focusing on short-term momentum or longer-term trend following, the platform provides traders with automated insights that can complement traditional analysis. I find this particularly useful when cross-checking signals during periods of sharp repricing like the one we’ve seen with Accenture.

What Investors Should Watch Next

Looking ahead, several factors will be critical for Accenture’s stock trajectory. The company’s fiscal fourth-quarter results, expected in September, will reveal whether the guidance cut was appropriately conservative or if further deterioration is underway. Investors should monitor new bookings closely — a rebound above $22 billion would signal recovering demand, while another sub-$20 billion quarter would deepen concerns. The integration and revenue contribution from the Dragos, runZero, and NetRise cybersecurity acquisitions will be scrutinized, particularly whether the combined $208 million in annual recurring revenue can scale meaningfully. The resolution of Middle East tensions and any stabilization in U.S. federal procurement could remove two identified headwinds. Additionally, commentary around AI-driven transformation projects converting from pilot programs to large-scale implementations will be pivotal in validating or challenging the bear thesis that AI is compressing rather than expanding Accenture’s addressable market. With the stock trading at a price-to-earnings ratio near 11 — a multi-year low — valuation may provide support if execution stabilizes.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ACN

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


ACN saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for ACN moved out of overbought territory on September 18, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 56 similar instances where the indicator exited the overbought zone. In 40 of the 56 cases the stock moved lower. This puts the odds of a downward move at 71%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ACN moved out of overbought territory on August 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 23 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.

The Momentum Indicator moved below the 0 level on September 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ACN as a result. In 52 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.

The Moving Average Convergence Divergence Histogram (MACD) for ACN turned negative on September 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 30 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.

Bullish Trend Analysis

Following a +9.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACN advanced for three days, in 187 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

ACN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 110 of 195 cases where ACN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 56%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.478) is normal, around the industry mean (7.717). P/E Ratio (14.480) is within average values for comparable stocks, (69.114). Projected Growth (PEG Ratio) (1.317) is also within normal values, averaging (2.305). ACN has a moderately high Dividend Yield (0.036) as compared to the industry average of (0.010). P/S Ratio (1.618) is also within normal values, averaging (145.217).

The Tickeron SMR rating for this company is 38 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. ACN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 71 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

Notable companies

The most notable companies in this group are International Business Machines Corp (NYSE:IBM), Accenture PLC (NYSE:ACN), Unisys Corp (NYSE:UIS).

Industry description

The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.

Market Cap

The average market capitalization across the Information Technology Services Industry is 8.84B. The market cap for tickers in the group ranges from 100 to 216.27B. IBM holds the highest valuation in this group at 216.27B. The lowest valued company is ARSC at 100.

High and low price notable news

The average weekly price growth across all stocks in the Information Technology Services Industry was 2%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 22%. VEEA experienced the highest price growth at 185%, while HLSQ experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Information Technology Services Industry was 133%. For the same stocks of the Industry, the average monthly volume growth was 61% and the average quarterly volume growth was -25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 64
Price Growth Rating: 59
SMR Rating: 72
Profit Risk Rating: 92
Seasonality Score: -2 (-100 ... +100)
View a ticker or compare two or three
ACN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an investment holding company with interest in providing management consulting, technology and outsourcing services

Industry InformationTechnologyServices

Profile
Details
Industry
Information Technology Services
Address
1 Grand Canal Square
Phone
+353 16462000
Employees
779000
Web
https://www.accenture.com
Interact to see
Advertisement
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.
Shares of KC surged approximately +17% in premarket trading on March 18, 2026, from a prior close of $13.12 to approximately $15.35. The primary catalyst is Kingsoft Cloud's release of its unaudited Q4 and full-year 2025 financial results before the U.S. market open, which appear to have significantly exceeded analyst expectations.
AngloGold Ashanti (AU) shares tumbled approximately 7% in premarket trading on March 18, 2026, extending a multi-week downtrend that has erased nearly 20% of the stock's value since late January highs. The primary catalyst driving the decline is persistent investor concern over AngloGold's lowered 2026 production guidance, with the company projecting gold output of 2.80–3.17 million ounces — a roughly 3% decline from its 2025 production of 3.1 million ounces.
AAOI shares surged approximately 10.90% in premarket trading on March 18, 2026, rising from a prior close of $86.33 to $95.74. The primary catalyst is strong positive sentiment generated at OFC 2026 — the Optical Fiber Communications Conference and Exhibition — where Applied Optoelectronics unveiled breakthrough laser and transceiver technology for next-generation AI data center infrastructure.
LITE shares surged approximately +12% in early Wednesday trading on March 18, 2026, with the stock changing hands near $727 compared to a prior session close of $649.56. The primary near-term catalyst is Lumentum's S&P 500 index inclusion, effective March 23, 2026, triggering front-running by institutional investors and mandatory buying by passive index funds.
Shares of New Era Energy & Digital, Inc. (NUAI) are trading down approximately 17% during today's session, with the prior close sitting at $5.56. The decline follows the company's March 17 business update conference call and webcast, held after market hours, during which management discussed the recently filed fiscal year 2025 annual report (Form 10-K).
Shares of Regencell Bioscience Holdings (RGC) are up approximately +16% intraday on March 18, 2026, trading at $26.56 against a prior close of $22.97. No single company-specific press release is driving today's move; the rally is primarily fueled by retail-driven momentum and short squeeze mechanics.
A jump in the Producer Price Index from 0.3% to around 0.7% month‑over‑month signals that wholesale inflation is re‑accelerating, delaying Fed rate‑cut hopes and reviving the “higher for longer” rates narrative.business. Likely winners in this environment include energy and commodity producers (XOM, CVX, TTE, COP), inflation‑resilient financials (JPM, BAC), and real‑asset plays like pipelines and infrastructure, which can pass through higher prices; ETFs like XLE, XOP, XLF, DBA, GLD offer diversified exposure.
BGSI fell more than 11% today, pulling back from recent levels around the high‑$150s as investors reassessed the risk‑reward following the Q4 2025 print and major U.S. expansion plans. Full‑year 2025 sales rose 2.4% to US$3.14 billion, but same‑store sales declined 0.2%, while reported net earnings fell 25% to US$18.4 million due to US$22.6 million in acquisition and transformation costs.